The Annual EURION Cluster meeting was held in Paris on 5 February 2020 and gave the eight cluster projects the opportunity to provide updates on their progress in the first year. Each project is focusing on a different aspect of new testing and screening methods identifying EDCs. At the annual meeting, the projects shared expertise to maximise EURION’s impact, and the event was an excellent opportunity to hear about what’s happening in the endocrine disruption research area worldwide.
Some of the highlights of the day included:
- Challenges of Endocrine Disrupting Chemicals, a keynote presentation by Dr Linda Birnbaum from NIEHS, USA;
- Progress updates from the EURION Working Group leaders;
- Regulatory challenges in Europe, a presentation by Dr Greg Moore from KEMI Sweden.
Morning: Open session (chaired by Karine Audouze and Juliette Legler)
9:00 Opening Karine Audouze, welcome from DG INSERM, Gilles Bloch
9:10 Welcome from the European Commission
- Tuomo Karjalainen, DG Research and Innovation – EU research on endocrine
disruptors - Mara Ceridono, DG Environment, Endocrine disruptors: EU legislation and policy
9:30 Intro to EURION – duo presentation by Juliette Legler and Karine Audouze
9:45 Keynote Dr Linda Birnbaum, NIEHS USA – Challenges of Endocrine Disrupting Chemicals
10:30 Break
11:15 Presentations by EURION Working Group leaders
- Prof. Pim Leonards, ENDpoiNTs: Chemicals
- Prof. Dries Knapen, ERGO: AOPs
- Prof. Andreas Kortenkamp, ATHENA: Regulatory Affairs
12:00 Presentation by Dr Greg Moore, KEMI Sweden – Regulatory challenges in Europe